Saraceni, F., & Bochtler, T. (2019). Fludarabine-treosulfan compared to thiotepa-busulfan-fludarabine or FLAMSA as conditioning regimen for patients with primary refractory or relapsed acute myeloid leukemia: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Journal of hematology & oncology, 12, . https://doi.org/10.1186/s13045-019-0727-4
Chicago-Zitierstil (17. Ausg.)Saraceni, Francesco, und Tilmann Bochtler. "Fludarabine-treosulfan Compared to Thiotepa-busulfan-fludarabine or FLAMSA as Conditioning Regimen for Patients with Primary Refractory or Relapsed Acute Myeloid Leukemia: A Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)." Journal of Hematology & Oncology 12 (2019). https://doi.org/10.1186/s13045-019-0727-4.
MLA-Zitierstil (9. Ausg.)Saraceni, Francesco, und Tilmann Bochtler. "Fludarabine-treosulfan Compared to Thiotepa-busulfan-fludarabine or FLAMSA as Conditioning Regimen for Patients with Primary Refractory or Relapsed Acute Myeloid Leukemia: A Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)." Journal of Hematology & Oncology, vol. 12, 2019, https://doi.org/10.1186/s13045-019-0727-4.